Powered by
LANSING–Ionetix Corp., a manufacturer of superconducting cyclotrons and producer of medical isotopes for diagnostic imaging and therapy, announced it has begun routine shipment of astatine-211 (At-211) in North America, marking …
ANN ARBOR–Sling Therapeutics, Inc., a biopharmaceutical company focused on late-stage development of an oral small molecule for the treatment of thyroid eye disease, announced the appointment of Ken Lock as …
ANN ARBOR–Courage Therapeutics, a biopharma company developing new treatments for obesity and eating disorders, today announced the appointment of Giovanni Ferrara as its new CEO. This announcement follows an investment …
ANN ARBOR–The biotech startup Akadeum Life Sciences announced the successful close of a $20 million+ financing round, led by Grand Rapids-based Michigan Capital Network, with participation from Ann Arbor-based Arboretum …
PLYMOUTH—Esperovax Inc., a private Michigan-based biotechnology company specializing in innovative circular RNA technologies announced today that DynPort Vaccine Company LLC, a General Dynamics Information Technology company, awarded Esperovax a two-year …
SOUTHFIELD—High school students will come to Lawrence Technological University in March to learn how to analyze DNA to detect genetically modified foods under a grant from the American Society of …
BLOOMFIELD HILLS–Zivo Bioscience Inc. (NASDAQ: ZIVO), a biotech and agricultural tech research and development company, announced a one-for-six-share reverse stock split, effective Friday, Oct. 26 at 5 p.m. Eastern time. …
KALAMAZOO–The medical device and technology manufacturer Stryker Corp. (NYSE: SYK announced that its Pangea Systems bone implant plates, including Femur, Fibula, Tibia, Humerus and Utility, have received 510k clearance from …
GRAND RAPIDS–Corium Pharma Solutions Inc., a contract development and manufacturing organization, today announced its new name, Corium Innovations Inc. Company officials said the name change reflects the company’s ongoing focus on offering …
ANN ARBOR–Upkara, a biotech startup, announced that it has secured $9 million in Series A funding, including additional investment from prominent businessman and philanthropist Bill Parfet, along with industry veteran, …